Robert McDowell
2015
In 2015, Robert McDowell earned a total compensation of $495K as Senior Vice President of Drug Discovery at MyoKardia, a 39% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $113,236 |
|---|---|
| Option Awards | $77,301 |
| Salary | $304,500 |
| Other | $500 |
| Total | $495,037 |
McDowell received $304.5K in salary, accounting for 62% of the total pay in 2015.
McDowell also received $113.2K in non-equity incentive plan, $77.3K in option awards and $500 in other compensation.
Rankings
In 2015, Robert McDowell's compensation ranked 10,862nd out of 13,638 executives tracked by ExecPay. In other words, McDowell earned more than 20.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,862 out of 13,638 | 20th |
Division Manufacturing | 4,148 out of 5,190 | 20th |
Major group Chemicals And Allied Products | 1,522 out of 1,854 | 18th |
Industry group Drugs | 1,256 out of 1,528 | 18th |
Industry Pharmaceutical Preparations | 979 out of 1,182 | 17th |
Source: SEC filing on April 28, 2016.
McDowell's colleagues
We found two more compensation records of executives who worked with Robert McDowell at MyoKardia in 2015.